Ozempic on Wall Street’s list for 2027 Medicare drug negotiations

Now that the US government has negotiated prices for some Medicare drugs that will take effect in 2026, Wall Street analysts are betting on a 2027 list that will include Novo Nordisk, which makes Ozempic for diabetes and has limited impact on big pharma.

Teile diesen Beitrag:

BELIEBTE BEITRÄGE
FOLGEN SIE UNS
Like uns auf Facebook
Folge uns auf Twitter
Abonniere unseren Kanal
Tick Tack
LIVEÜBERTRAGUNG